Ascensia Diabetes Care, a company based in Basel, Switzerland, won FDA clearance to bring to the U.S. market its CONTOUR NEXT ONE blood glucometer. The device has Bluetooth wireless connectivity that allows diabetics to upload their readings to a paired app on their iOS or Android smartphones.
The CONTOUR DIABETES app provides historical charts of blood sugar levels and lets patients understand how their diet and physical activity impacts those. This works best if the patient religiously enters the details of his/or her food intake and all the activities that take place throughout the day. All the readings and entered information can be uploaded to the “cloud” and reviewed on a computer. Reports can be emailed to one’s physician or family members to make sure everyone is on the same page and helping to keep the symptoms of diabetes in check.
The device works just fine on its own without the app, displaying readings on a built-in screen. An indicator on the left side of the device turns green, yellow, or red depending on how out of normal range the last reading was. Ascensia claims this is one of the most accurate blood glucose meters on the market, achieving ±8.4% accuracy on 95% of readings when it was compared against laboratory equipment in a small trial with human subjects.
The CONTOUR NEXT ONE will be available for purchase in the U.S. early next year and the app will show up on Apple App Store and Google Play for downloading.